279 related articles for article (PubMed ID: 17351108)
1. Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice.
Raveche ES; Salerno E; Scaglione BJ; Manohar V; Abbasi F; Lin YC; Fredrickson T; Landgraf P; Ramachandra S; Huppi K; Toro JR; Zenger VE; Metcalf RA; Marti GE
Blood; 2007 Jun; 109(12):5079-86. PubMed ID: 17351108
[TBL] [Abstract][Full Text] [Related]
2. Alterations in the mir-15a/16-1 Loci Impairs Its Processing and Augments B-1 Expansion in De Novo Mouse Model of Chronic Lymphocytic Leukemia (CLL).
Kasar S; Underbayev C; Hassan M; Ilev I; Degheidy H; Bauer S; Marti G; Lutz C; Raveche E; Batish M
PLoS One; 2016; 11(3):e0149331. PubMed ID: 26959643
[TBL] [Abstract][Full Text] [Related]
3. Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model.
Scaglione BJ; Salerno E; Balan M; Coffman F; Landgraf P; Abbasi F; Kotenko S; Marti GE; Raveche ES
Br J Haematol; 2007 Dec; 139(5):645-57. PubMed ID: 17941951
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic implications of activation of the host gene (Dleu2) promoter for miR-15a/16-1 in chronic lymphocytic leukemia.
Kasar S; Underbayev C; Yuan Y; Hanlon M; Aly S; Khan H; Chang V; Batish M; Gavrilova T; Badiane F; Degheidy H; Marti G; Raveche E
Oncogene; 2014 Jun; 33(25):3307-15. PubMed ID: 23995789
[TBL] [Abstract][Full Text] [Related]
5. Correcting miR-15a/16 genetic defect in New Zealand Black mouse model of CLL enhances drug sensitivity.
Salerno E; Scaglione BJ; Coffman FD; Brown BD; Baccarini A; Fernandes H; Marti G; Raveche ES
Mol Cancer Ther; 2009 Sep; 8(9):2684-92. PubMed ID: 19723889
[TBL] [Abstract][Full Text] [Related]
6. The New Zealand black mouse as a model for the development and progression of chronic lymphocytic leukemia.
Salerno E; Yuan Y; Scaglione BJ; Marti G; Jankovic A; Mazzella F; Laurindo MF; Despres D; Baskar S; Rader C; Raveche E
Cytometry B Clin Cytom; 2010; 78 Suppl 1(Suppl 1):S98-109. PubMed ID: 20839343
[TBL] [Abstract][Full Text] [Related]
7. Role of mir-15a/16-1 in early B cell development in a mouse model of chronic lymphocytic leukemia.
Underbayev C; Kasar S; Ruezinsky W; Degheidy H; Schneider JS; Marti G; Bauer SR; Fraidenraich D; Lightfoote MM; Parashar V; Raveche E; Batish M
Oncotarget; 2016 Sep; 7(38):60986-60999. PubMed ID: 27533467
[TBL] [Abstract][Full Text] [Related]
8. Systemic in vivo lentiviral delivery of miR-15a/16 reduces malignancy in the NZB de novo mouse model of chronic lymphocytic leukemia.
Kasar S; Salerno E; Yuan Y; Underbayev C; Vollenweider D; Laurindo MF; Fernandes H; Bonci D; Addario A; Mazzella F; Raveche E
Genes Immun; 2012 Feb; 13(2):109-19. PubMed ID: 21881595
[TBL] [Abstract][Full Text] [Related]
9. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia.
Klein U; Lia M; Crespo M; Siegel R; Shen Q; Mo T; Ambesi-Impiombato A; Califano A; Migliazza A; Bhagat G; Dalla-Favera R
Cancer Cell; 2010 Jan; 17(1):28-40. PubMed ID: 20060366
[TBL] [Abstract][Full Text] [Related]
10. Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy.
Cutrona G; Matis S; Colombo M; Massucco C; Baio G; Valdora F; Emionite L; Fabris S; Recchia AG; Gentile M; Neumaier CE; Reverberi D; Massara R; Boccardo S; Basso L; Salvi S; Rosa F; Cilli M; Zupo S; Truini M; Tassone P; Calabrese M; Negrini M; Neri A; Morabito F; Fais F; Ferrarini M
Leukemia; 2017 Sep; 31(9):1894-1904. PubMed ID: 28053325
[TBL] [Abstract][Full Text] [Related]
11. Genetic factors predisposing to B-CLL and to autoimmune disease in spontaneous murine model.
Hirose S; Hamano Y; Shirai T
Leukemia; 1997 Apr; 11 Suppl 3():267-70. PubMed ID: 9209361
[TBL] [Abstract][Full Text] [Related]
12. Functional dissection of the chromosome 13q14 tumor-suppressor locus using transgenic mouse lines.
Lia M; Carette A; Tang H; Shen Q; Mo T; Bhagat G; Dalla-Favera R; Klein U
Blood; 2012 Mar; 119(13):2981-90. PubMed ID: 22174151
[TBL] [Abstract][Full Text] [Related]
13. Accelerated development of chronic lymphocytic leukemia in New Zealand Black mice expressing a low level of interferon regulatory factor 4.
Ma S; Shukla V; Fang L; Gould KA; Joshi SS; Lu R
J Biol Chem; 2013 Sep; 288(37):26430-40. PubMed ID: 23897826
[TBL] [Abstract][Full Text] [Related]
14. Altered CD45 expression in malignant B-1 cells.
Dang AM; Phillips JA; Lin T; Raveche ES
Cell Immunol; 1996 May; 169(2):196-207. PubMed ID: 8620547
[TBL] [Abstract][Full Text] [Related]
15. Hyperdiploid-CD5-positive B cells in mouse.
Raveche ES; Tjio JH
Int J Hematol; 1991 Feb; 54(1):25-35. PubMed ID: 1954348
[TBL] [Abstract][Full Text] [Related]
16. New insights into the pathogenesis of chronic lymphocytic leukemia.
Klein U; Dalla-Favera R
Semin Cancer Biol; 2010 Dec; 20(6):377-83. PubMed ID: 21029776
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of miR-15a and miR-16-1 at 13q14 in Chronic Lymphocytic Leukemia.
Acunzo M; Croce CM
Clin Chem; 2016 Apr; 62(4):655-6. PubMed ID: 26908869
[No Abstract] [Full Text] [Related]
18. The NZB mouse as a model for chronic lymphocytic leukemia.
Phillips JA; Mehta K; Fernandez C; Raveché ES
Cancer Res; 1992 Jan; 52(2):437-43. PubMed ID: 1370214
[TBL] [Abstract][Full Text] [Related]
19. Loss of a chromosomal region with synteny to human 13q14 occurs in mouse chronic lymphocytic leukemia that originates from early-generated B-1 B cells.
Hayakawa K; Formica AM; Colombo MJ; Shinton SA; Brill-Dashoff J; Morse Iii HC; Li YS; Hardy RR
Leukemia; 2016 Jul; 30(7):1510-9. PubMed ID: 27055869
[TBL] [Abstract][Full Text] [Related]
20. Requirement for increased IL-10 in the development of B-1 lymphoproliferative disease in a murine model of CLL.
Ramachandra S; Metcalf RA; Fredrickson T; Marti GE; Raveche E
J Clin Invest; 1996 Oct; 98(8):1788-93. PubMed ID: 8878429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
